Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 6—June 2004

Dispatch

Antibacterial Resistance, Wayampis Amerindians, French Guyana

Karine Grenet*, Didier Guillemot†, Vincent Jarlier‡, Brigitte Moreau§, Stéphane Dubourdieu*, Raymond Ruimy*, Laurence Armand-Lefevre*, Pierre Bau*, and Antoine Andremont*Comments to Author 
Author affiliations: *Assistance Publique-Hôpitaux de Paris, Paris, France; †Pharmaco-Épidémiologie Institut Pasteur, Paris, France; ‡Groupe Hospitalier Pitié-Salpêtrière, Paris, France; §Centre Hospitalier de Cayenne, French Guyana

Main Article

Table 1

Antibacterial exposure in 388 Wayampi American Indians from three villages in southern French Guyana during the year preceding the studya

Antibacterial agents Frequency of antibacterial exposure in (%)
TS
(n = 85) YP
(n = 55) Z
(n = 248) Total
(n = 388) p valueb
Aminopenicillins
5.9
14.6
23.8
18.6
0.007
Metronidazole
16.5
30.9
32.3
28.6
0.15
Macrolides
8.2
1.8
11.3
9.3
0.2
Other
5.8
7.3
8.9
8.0
0.7
Overall 36.5 54.6 76.2 64.4 0.007

aFrequency of antibacterial exposure was calculated by dividing the number of all antibacterial courses during the year preceding the study by the number of persons in each village.
bAnalysis of variance (ANOVA).

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO